Welcome to our dedicated page for Precision Optics news (Ticker: POCI), a resource for investors and traders seeking the latest updates and insights on Precision Optics stock.
Precision Optics Corporation, Inc. (NASDAQ: POCI) is a vertically integrated optics company focused on advanced optical instruments for healthcare and defense/aerospace markets. This news page aggregates company announcements, press releases and other updates related to POCI’s operations, projects and financial performance.
Readers can follow news about Precision Optics’ work in micro-optics, 3D imaging and digital imaging technologies, including developments in minimally invasive surgery imaging, 3D endoscopy and optical systems that support surgical robotic platforms. Updates often highlight new engineering and production programs, such as complex endocouplers, specialized endoscopes and single-use endoscope assemblies for leading medical device companies.
In defense and aerospace, company news covers product development orders and collaborations involving compact, high-performance optical systems. Recent releases describe sub-assemblies for advanced augmented reality systems for fighter pilot training and high-end, small-diameter borescopes for jet engine inspection in extreme environmental conditions. These items illustrate how Precision Optics applies its micro-optics and imaging capabilities to demanding military and aerospace applications.
Investors and analysts can also review announcements of quarterly and annual financial results, including details on engineering versus production revenue, gross margins, net income (loss) and the company’s use of non-GAAP measures such as Adjusted EBITDA. Conference call schedules, investor conference participation and facility expansion plans, including moves to support a growing production backlog and broader engineering talent pool, are also covered.
For anyone tracking POCI stock or the company’s role in medical and defense/aerospace optics, this page provides a centralized view of official news, helping users understand how new contracts, development agreements and operational updates relate to the company’s long-term strategy.
Precision Optics (NASDAQ: POCI) reported Q1 fiscal 2026 results for the quarter ended September 30, 2025, with record revenue of $6.68M (up ~59% year-over-year) driven by production deliveries. Production revenue rose to $6.0M (up ~133% YoY) while engineering revenue fell to $0.7M (down 59% YoY). Gross margin declined to 14.2% from 26.6% a year earlier. Net loss was $1.64M and Adjusted EBITDA was $(1.2)M for the quarter. Recent wins include two development agreements worth $700k and $678k. Fiscal 2026 guidance projects revenue to exceed $25M (≈31% growth) and Adjusted EBITDA of about $0.5M.
Precision Optics (NASDAQ: POCI) announced a $678,000 product development order dated Nov 11, 2025 to design and build a next‑generation, small‑diameter borescope for jet engine inspection for a large aerospace and defense customer. The borescope is specified to deliver >1080p HD resolution, multiple configurations, and endurance for extreme engine environments. The award followed an onsite supplier evaluation in which POCI competed against three finalists. The order is for development work (not a production contract) and was described by management as validation of the company’s imaging and integration capabilities and a potential pathway to future opportunities.
Precision Optics (NASDAQ: POCI) announced a product development order dated Nov 7, 2025 to build compact optical sub-assemblies for an augmented reality (AR) system intended for US Air Force fighter pilot in-air training.
The initial $723,000 development order covers design, prototyping and qualification of next-generation, reduced size/weight/power optical systems to enable pilots to wear AR headsets during flight and reduce secondary-aircraft training needs.
Precision Optics (Nasdaq: POCI) scheduled a conference call to discuss its first quarter fiscal 2026 financial results on Thursday, November 13, 2025 at 5:00 p.m. ET. The company said it will release results and file its Form 10-Q after market close on November 13, 2025, followed by the call.
Access: live dial-in at (844) 735-3662 or (412) 317-5705, live webcast at https://app.webinar.net/3PyMqXG06ZY. A teleconference replay will be available for seven days at (877) 344-7529 or (412) 317-0088 (access code 7772062); webcast replay available at the same webinar link.
Precision Optics (Nasdaq: POCI), a leading designer and manufacturer of advanced optical instruments for medical and defense/aerospace industries, has announced its participation in the virtual Lytham Partners Fall 2025 Investor Conference on September 30, 2025.
The company will deliver a webcast presentation at 10:15 a.m. ET and conduct one-on-one meetings with investors throughout the event. Interested parties can access the webcast through the conference website, with replay available after the event.
Precision Optics (NASDAQ: POCI) reported Q4 and FY 2025 financial results, with record Q4 revenue of $6.2 million, up 48% year-over-year. FY 2025 revenue was $19.1 million, with production revenue growing 34% to $14.2 million. The company reported a net loss of $(5.8) million for FY 2025.
For FY 2026, POCI projects revenue exceeding $25 million (31% growth) and expects gross margins to improve to approximately 30% from 18% in FY 2025. The company anticipates Adjusted EBITDA of $0.5 million in FY 2026, compared to $(3.7) million in FY 2025.
Additionally, POCI appointed Joseph Traut as new Chief Operating Officer effective October 1, 2025, granting him inducement stock options for 60,000 shares.
Precision Optics (Nasdaq: POCI), a leading designer and manufacturer of advanced optical instruments for medical and defense/aerospace industries, has scheduled its fourth quarter and fiscal year 2025 financial results conference call for September 29, 2025, at 5:00 p.m. ET.
The company will release its financial results and file its 10-K after market close on the same day. Investors can join via phone at (844) 735-3662 or (412) 317-5705, or through a live webcast. A replay will be available for seven days following the call.
Precision Optics (Nasdaq: POCI), a designer and manufacturer of advanced optical instruments for medical and defense/aerospace industries, will participate in the Lytham Partners 2025 Consumer & Technology Investor Summit on August 19, 2025.
The company's virtual presentation is scheduled for 9:30 a.m. ET and will be accessible through the conference website. A replay of the webcast will be available following the presentation.
Precision Optics Corporation (NASDAQ: POCI), a specialized manufacturer of advanced optical instruments for medical and defense/aerospace sectors, has announced its participation in the upcoming Lytham Partners Spring 2025 Investor Conference on May 29, 2025.
The company will deliver a webcast presentation at 10:15 a.m. ET and conduct one-on-one meetings with investors throughout the virtual event. Interested participants can access the webcast through the conference website or arrange individual meetings with management through Lytham Partners.
FAQ
What is the current stock price of Precision Optics (POCI)?
What is the market cap of Precision Optics (POCI)?
